Skip to playerSkip to main content
  • 4 hours ago
Dr. Marty Makary, the FDA Commissioner, has stepped down, leaving the agency without confirmed leadership as it navigates the hantavirus outbreak on a cruise ship and several ongoing reviews of pharmaceutical safety. The FDA oversees products that account for about 20 cents of every dollar spent by Americans. Former officials from the FDA are openly voicing their worries regarding the perilous timing of this leadership void.

Category

πŸ—ž
News
Transcript
00:00The United States Food and Drug Administration is now without a confirmed leader,
00:04in the middle of one of the most complex public health moments in years.
00:08And health experts are raising urgent concerns about the timing.
00:12Dr. Marty McCary resigned as FDA commissioner this morning,
00:16becoming the fourth high-profile official to leave the Trump administration this year.
00:21The resignation comes as the Hantavirus cruise ship outbreak is being actively managed,
00:26as ongoing drug safety reviews are in progress.
00:30Across multiple pharmaceutical products, and as the annual food safety inspection cycle,
00:35is underway across U.S. food processing facilities.
00:38The FDA is responsible for regulating products, that account for roughly 20 cents,
00:44of every dollar Americans spend.
00:46Without confirmed leadership, agency career officials will run day-to-day operations,
00:51but major regulatory decisions, public communications, and congressional testimony will be paused or delayed.
00:58Former FDA officials say they are deeply concerned about the vacuum this creates.
01:03At a moment when public health demands clarity and authority,
01:06So the FDA is responsible for managing all the Trade Services.
01:06So the FDA is responsible for managing all the drugs can provide every single-level day,
01:07The FDA is just because it needs a political report for any customer service.
Comments

Recommended